05:44 PM EST, 02/05/2026 (MT Newswires) -- Adaptive Biotechnologies ( ADPT ) reported Q4 net loss late Thursday of $0.09 per diluted share, narrowing from $0.23 a year earlier.

Analysts polled by FactSet expected loss of $0.19.

Revenue for the quarter ended Dec. 31 was $71.7 million, up from $47.5 million a year earlier.

Analysts expected $60.9 million.

As of Dec. 31, the company said it had $240.2 million in cash, cash equivalents, and marketable securities.